🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assessment of effectiveness, safety and local immune activation of Oncolyti...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-03-05
Trial ID
NCT04771676
Treatments Being Tested
This study aims to evaluate the safety and effectiveness of a combination t...
Status
Not Yet Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2026-05-01
Trial ID
NCT07543848
Treatments Being Tested
Sorafenib, as a first-line treatment for patients with advanced HCC, can si...
Status
Unknown
Location
Shaanxi Provincial People's Hospital
Start Date
2021-12-28
Trial ID
NCT05113290
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of oncol...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-05-16
Trial ID
NCT05823987
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Oncolyt...
Status
Unknown
Location
Tianjin Medical Unversity Second Hospital
Start Date
2023-07-20
Trial ID
NCT06031636
Treatments Being Tested
There is no standard treatment for recurrent cervical cancer that progresse...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2022-03
Trial ID
NCT05234905
Treatments Being Tested
The objective of this study is to evaluate the safety/tolerability efficacy...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2023-03-01
Trial ID
NCT05675462
Treatments Being Tested
H101 is an E1B55KD deleted oncolytic adenovirus, which is the first and onl...
Status
Unknown
Location
Hua Wang
Start Date
2022-08-26
Trial ID
NCT05564897
Treatments Being Tested
Oncolytic viruses can selectively replicate in and destroy tumor cells. Rec...
Status
Unknown
Location
Beijing Tsinghua Chang Gung Hospital
Start Date
2022-08-01
Trial ID
NCT05124002
Treatments Being Tested